In this connection, further research is needed to elucidate the specific molecular mechanisms by which SIGMAR1 modulates PD-L1 expression and its implications for oral cancer progression and immunotherapy response. The gene discussed is SIGMAR1; the disease is lip and oral cavity carcinoma.